bf/NASDAQ:CUE_icon.jpeg

NASDAQ:CUE

Cue Biopharma, Inc.

  • Stock

0.75

−0.44%

−0.04

USD last updated 13/08 01:59:42

Last Close

0.79

12/08 22:07

Market Cap

43.11M

Beta: 2.00

Volume Today

48.55K

Avg: 186.50K

PE Ratio

−2.14

PFCF: −2.73

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cel...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.5-0.4-0.3-0.2-0.12018-08-132020-08-072022-08-042024-04-082024-11-07

    Revenue (Estimate*)

    2M4M6M8M2018-08-132020-08-072022-08-042024-04-082024-11-07

    *Estimate based on analyst consensus